J
Jan Lunemann
Researcher
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
NOV 2
Jul 15, 2026
Jan D Lünemann and Christian Münz on Epstein–Barr virus and multiple sclerosis
5:45
5:57
6:14
6:26
6:43
11:18

Heather BrownHOST
And why out of all the people who have been infected with EBV do only a very small proportion go on to develop MS?

Jan LunemannGUEST
I mean, EBV infection appears to be necessary but, uh, not sufficient to cause MS. Um, as said, more than 90% of people are infected worldwide with EBV, yet only around one in 500 or 1,000 in milder latitudes develops MS.

Jan LunemannGUEST
And this tells us that MS is, uh, resulting from the convergence of several risk factors rather than, than a single cause.

Jan LunemannGUEST
More than 200 genetic susceptibility variants have now been identified, the strongest effect coming from the HLA-DB1501 allele, which encodes for the HLA-DA2 haplotype, the molecule that presents antigens to CD4 T cells, but other risk alleles have been identified.

Jan LunemannGUEST
Many of these risk genes regulate immune function, and interestingly, several are directly influenced, kind of activated by the EBV transcription factor EBNA2.

Heather BrownHOST
And what are the main things that we still don't know about EBV and MS, and what do you think are the most important next steps for the field?